Palestine · Delayed Price · Currency is JOD · Price in USD Jerusalem Pharmaceuticals Statistics
Total Valuation
PEX:JPH has a market cap or net worth of JOD 93.90 million. The enterprise value is 88.13 million.
| Market Cap | 93.90M |
| Enterprise Value | 88.13M |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | Apr 16, 2026 |
Share Statistics
PEX:JPH has 36.00 million shares outstanding.
| Current Share Class | 36.00M |
| Shares Outstanding | 36.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 42.30% |
| Owned by Institutions (%) | 6.39% |
| Float | 13.79M |
Valuation Ratios
The trailing PE ratio is 12.96.
| PE Ratio | 12.96 |
| Forward PE | n/a |
| PS Ratio | 2.64 |
| PB Ratio | 1.46 |
| P/TBV Ratio | 1.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 12.16 |
| EV / Sales | 2.48 |
| EV / EBITDA | 8.16 |
| EV / EBIT | 9.29 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.42, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.42 |
| Quick Ratio | 2.55 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.15 |
| Debt / FCF | -0.68 |
| Interest Coverage | 424.15 |
Financial Efficiency
Return on equity (ROE) is 12.59% and return on invested capital (ROIC) is 13.28%.
| Return on Equity (ROE) | 12.59% |
| Return on Assets (ROA) | 8.02% |
| Return on Invested Capital (ROIC) | 13.28% |
| Return on Capital Employed (ROCE) | 13.70% |
| Weighted Average Cost of Capital (WACC) | 6.52% |
| Revenue Per Employee | 59,782 |
| Profits Per Employee | 12,176 |
| Employee Count | 595 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 1.95 |
Taxes
In the past 12 months, PEX:JPH has paid 1.91 million in taxes.
| Income Tax | 1.91M |
| Effective Tax Rate | 20.67% |
Stock Price Statistics
The stock price has increased by +89.09% in the last 52 weeks. The beta is 0.43, so PEX:JPH's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | +89.09% |
| 50-Day Moving Average | 3.29 |
| 200-Day Moving Average | 2.33 |
| Relative Strength Index (RSI) | 54.68 |
| Average Volume (20 Days) | 1,991 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PEX:JPH had revenue of JOD 35.57 million and earned 7.24 million in profits. Earnings per share was 0.20.
| Revenue | 35.57M |
| Gross Profit | 20.58M |
| Operating Income | 9.48M |
| Pretax Income | 9.22M |
| Net Income | 7.24M |
| EBITDA | 10.61M |
| EBIT | 9.48M |
| Earnings Per Share (EPS) | 0.20 |
Balance Sheet
The company has 8.20 million in cash and 1.62 million in debt, with a net cash position of 6.58 million or 0.18 per share.
| Cash & Cash Equivalents | 8.20M |
| Total Debt | 1.62M |
| Net Cash | 6.58M |
| Net Cash Per Share | 0.18 |
| Equity (Book Value) | 64.11M |
| Book Value Per Share | 3.52 |
| Working Capital | 33.71M |
Cash Flow
In the last 12 months, operating cash flow was -1.32 million and capital expenditures -1.07 million, giving a free cash flow of -2.38 million.
| Operating Cash Flow | -1.32M |
| Capital Expenditures | -1.07M |
| Depreciation & Amortization | 1.09M |
| Net Borrowing | -429,804 |
| Free Cash Flow | -2.38M |
| FCF Per Share | -0.07 |
Margins
Gross margin is 57.85%, with operating and profit margins of 26.66% and 20.37%.
| Gross Margin | 57.85% |
| Operating Margin | 26.66% |
| Pretax Margin | 25.93% |
| Profit Margin | 20.37% |
| EBITDA Margin | 29.82% |
| EBIT Margin | 26.66% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 2.06%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 2.06% |
| Dividend Growth (YoY) | 274.83% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 13.43% |
| Buyback Yield | n/a |
| Shareholder Yield | 2.06% |
| Earnings Yield | 7.72% |
| FCF Yield | -2.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 16, 2026. It was a forward split with a ratio of 2.
| Last Split Date | Apr 16, 2026 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |